Gene Therapy for Cancer Market Set to Grow at an Impressive CAGR of 12.6% Through 2035 | USD 20 Billion

WiseGuy Reports, Sept. 2025 (Press Release) – The Gene Therapy for Cancer Market Global Outlook:

Gene Therapy for Cancer Market Size, Share & Industry Analysis By Therapeutic Approach (Gene Editing, Gene Replacement, Oncolytic Virus Therapy, Immune Modulation), By Cancer Type (Leukemia, Melanoma, Breast Cancer, Lung Cancer), By Administration Route (Intravenous, Intratumoral, Subcutaneous, Intrathecal), By Product Type (Viral Vector Products, Non-Viral Products, Gene-modified Cell Products) and Regional Forecasts, 2025-2032

Gene Therapy for Cancer Market Future Scope:

The future of the healthcare industry is set to be transformed by technology, innovation, and patient-centered care. Artificial intelligence and machine learning will enhance diagnostics, enabling earlier disease detection and personalized treatment plans. Telemedicine and digital health platforms will expand access to care, particularly in remote areas. Wearable devices and health apps will empower patients to monitor their well-being in real time. Precision medicine, driven by genomics, will create tailored therapies for individuals. Robotics and automation will streamline surgeries and hospital workflows. Sustainability and value-based care will remain key priorities, making healthcare more efficient, affordable, and patient-focused.

Gene Therapy for Cancer Market Overview

Market Overview

The Gene Therapy for Cancer Market is experiencing significant growth as healthcare providers, pharmaceutical firms, and biotech investors increasingly focus on advanced cancer treatment solutions. Valued at USD 5.4 billion in 2024, the market is expected to reach USD 6.1 billion in 2025 and expand to USD 20.0 billion by 2035, representing a CAGR of 12.6%. B2B stakeholders are adopting gene therapies to enhance patient outcomes, reduce treatment resistance, and deliver personalized care options.

Request To Free Sample of This Strategic Report –

https://www.wiseguyreports.com/sample-request?id=547613

Key Market Dynamics

Several factors are propelling the growth of the Gene Therapy for Cancer Market:

• Increasing cancer prevalence: Rising incidence of breast, lung, colorectal, and hematologic cancers drives demand for innovative therapies.
• Advances in gene editing: CRISPR and viral vector technologies enable targeted cancer therapies with higher efficacy.
• Growing investment in R&D: Pharmaceutical and biotechnology companies are investing heavily in clinical trials, pipeline expansion, and novel gene therapy platforms.
• Regulatory approvals and guidelines: Favorable regulatory frameworks are accelerating the introduction of new therapies in oncology.
• Rising patient awareness: Increased understanding of gene therapy benefits is fostering demand in hospitals, specialty clinics, and research institutions.

These dynamics make the market an attractive space for B2B collaborations, licensing deals, and technological partnerships.

🛒 Buy Now Premium Research Report –

https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=547613

Segmental Insights

The Gene Therapy for Cancer Market is segmented by Therapeutic Approach, Cancer Type, Administration Route, Product Type, and Region:

• Therapeutic Approach: CAR-T therapy, oncolytic virus therapy, gene-modified T-cell therapy, and gene silencing approaches.
• Cancer Type: Hematologic malignancies, solid tumors, and rare cancers.
• Administration Route: Intravenous, intratumoral, and localized delivery methods to enhance treatment efficacy.
• Product Type: Vectors, reagents, and ready-to-use therapies designed for research, clinical trials, and commercial application.

These segments highlight the versatility and scope of gene therapies, enabling B2B players to address diverse treatment needs across oncology centers and research labs.

Regional Analysis

Regional adoption trends reveal varied growth opportunities:

• North America: Dominates the market due to advanced healthcare infrastructure, strong R&D presence, and early adoption of gene therapies.
• Europe: Germany, the UK, and France lead with supportive regulations, high patient awareness, and investments in oncology research.
• Asia-Pacific: China, Japan, and India show rapid growth potential driven by increasing cancer incidence, growing biotech investments, and expanding healthcare access.
• South America: Brazil, Mexico, and Argentina are gradually adopting gene therapy through partnerships with global pharmaceutical firms.
• Middle East & Africa: GCC countries and South Africa focus on improving oncology treatment standards, supported by emerging healthcare initiatives.

Competitive Landscape

The Gene Therapy for Cancer Market is competitive, with companies emphasizing innovation, collaborations, and portfolio expansion. Key players profiled include:

• Novartis
• Rocket Pharmaceuticals
• Bluebird Bio
• Celyad Oncology
• Spark Therapeutics
• Zymeworks
• Bristol Myers Squibb
• Sangamo Therapeutics
• Amgen
• Johnson & Johnson
• Regeneron Pharmaceuticals
• Sigilon Therapeutics
• Gilead Sciences
• Tessa Therapeutics
• Astellas Pharma

These firms focus on pipeline expansion, clinical trial development, and strategic alliances to capitalize on the growing gene therapy demand in oncology.

Market Opportunities

B2B stakeholders can leverage several opportunities in the Gene Therapy for Cancer Market:

• Increasing prevalence of cancer driving demand for targeted therapies.
• Advancements in CRISPR technology enabling precise and effective gene editing solutions.
• Growing patient awareness and demand for personalized cancer care.
• Rising investments in biotech fostering innovation and commercialization of new therapies.
• 
  

Reasons To Buy The Gene Therapy for Cancer Market Report:

➼ In-depth analysis of the Gene Therapy for Cancer Market on the global and regional levels.

➼ Major changes in market dynamics and competitive landscape.

➼ Segmentation on the basis of type, application, geography, and others.

➼ Historical and future market research in terms of size, share growth, volume, and sales.

➼ Major changes and assessment in market dynamics and developments.

➼ Emerging key segments and regions

➼ Key business strategies by major market players and their key methods

Avail This Gene Therapy for Cancer Market Language Pages Here:

がん遺伝子治療市場規模 | Marktanteil der Gentherapie bei Krebs | Analyse du marché de la thérapie génique contre le cancer | 암 유전자 치료 시장 분석 | 癌症基因治疗市场概况 | Tendencias del mercado de la terapia génica para el cáncer

Other Related Reports from WiseGuy Research References

Triamcinolone Acetonide Ointment Market | トリアムシノロンアセトニド軟膏の市場規模 | Marktanteil von Triamcinolonacetonid-Salbe | Analyse du marché de la pommade à l'acétonide de triamcinolone | 트리암시놀론 아세토니드 연고 시장 분석 | 曲安奈德软膏市场概况 | Tendencias del mercado de ungüentos de acetónido de triamcinolona

OTC Antihistamine Market | 市販抗ヒスタミン薬の市場規模 | Marktanteil rezeptfreier Antihistaminika | Analyse du marché des antihistaminiques en vente libre | OTC 항히스타민제 시장 분석 | 非处方抗组胺药市场概况 | Tendencias del mercado de antihistamínicos de venta libre

Nonsurgical Rhinoplasty Market | 非外科的鼻形成術の市場規模 | Marktanteil der nicht-chirurgischen Nasenkorrektur | Analyse du marché de la rhinoplastie non chirurgicale | 비수술적 코 성형 시장 분석 | 非手术隆鼻市场概况 | Tendencias del mercado de la rinoplastia no quirúrgica

Triumeq Market | トリウメク市場規模 | Marktanteil von triumeq | Analyse du marché de Triumeq | triumeq 시장 분석 | triumeq市场概览 | Tendencias del mercado de triumeq

Acne Patches Market | ニキビパッチ市場規模 | Marktanteil von Aknepflastern | Analyse du marché des patchs contre l'acné | 여드름 패치 시장 분석 | 痤疮贴片市场概览 | Tendencias del mercado de parches para el acné

Turmeric Supplement Market | ウコンサプリメント市場規模 | Marktanteil von Kurkuma-Ergänzungsmitteln | Analyse du marché des suppléments de curcuma | 강황 보충제 시장 분석 | 姜黄补充剂市场概况 | Tendencias del mercado de suplementos de cúrcuma

Valacyclovir Market | バラシクロビル市場規模 | Valacyclovir-Marktanteil | Analyse du marché du valacyclovir | 발라시클로비르 시장 분석 | 伐昔洛韦市场概览 | Tendencias del mercado del valaciclovir

Cytochrome C Market | シトクロムc市場規模 | Cytochrom C Marktanteil | Analyse du marché du cytochrome c | 시토크롬 c 시장 분석 | 细胞色素c市场概览 | Tendencias del mercado del citocromo c

Halobetasol Propionate Market | ハロベタゾールプロピオン酸エステル市場規模 | Marktanteil von Halobetasolpropionat | Analyse du marché du propionate d'halobétasol | 할로베타솔 프로피오네이트 시장 분석 | 丙酸卤倍他索市场概况 | Tendencias del mercado del propionato de halobetasol

About US:

Wise Guy Reports is pleased to introduce itself as a leading provider of insightful market research solutions that adapt to the ever-changing demands of businesses around the globe. We want our clients to have information that can be used to act upon their strategic initiatives. We, therefore, aim to be your trustworthy partner within dynamic business settings through excellence and innovation. By offering comprehensive market intelligence, our company enables corporate organizations to make informed choices, drive growth, and stay ahead in competitive markets